Clearmind Medicine (CMND) Total Liabilities (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Total Liabilities of $3.0 million for Q2 2026, up 5.34% year-over-year from $2.9 million in Q2 2025, and up 4.4% quarter-over-quarter from $2.9 million in Q1 2026.
Clearmind Medicine (CMND) Total Liabilities (2021 - 2026) Analysis & Trends
Clearmind Medicine's Total Liabilities history runs 6 years deep, the most recent figure standing at $3.0 million for Q2 2026.
- In Q2 2026, Total Liabilities rose 5.34% year-over-year to $3.0 million; the TTM figure through Apr 2026 stood at $3.0 million (up 5.34% YoY), while the FY2025 annual figure was $4.9 million, up 17.9% from the prior year.
- Total Liabilities for Q2 2026 stood at $3.0 million, up from $2.9 million in the prior quarter.
- The five-year high for Total Liabilities was $5.1 million in Q1 2024, with the low at $794568.0 in Q1 2023.
- The 5-year median for Total Liabilities is $3.0 million (2026), against an average of $3.4 million.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities surged 598.99% in 2022, then slumped 38.22% in 2025.
- Clearmind Medicine's Total Liabilities stood at $2.0 million in 2022, then jumped by 150.27% to $5.0 million in 2023, then slipped by 16.54% to $4.1 million in 2024, then climbed by 17.9% to $4.9 million in 2025, then sank by 37.99% to $3.0 million in 2026.
- Business Quant data shows CMND's Total Liabilities at $3.0 million in Q2 2026, $2.9 million in Q1 2026, and $4.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 10.03 Bn |
| 10 | Clearmind Medicine | 540,485.35 | -13.05 Mn | - | 3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.03 Mn |
| Jan 31, 2026 | 2.91 Mn |
| Oct 31, 2025 | 4.89 Mn |
| Jul 31, 2025 | 2.90 Mn |
| Apr 30, 2025 | 2.88 Mn |
| Jan 31, 2025 | 3.73 Mn |
| Oct 31, 2024 | 4.15 Mn |
| Jul 31, 2024 | 4.70 Mn |
| Apr 30, 2024 | 4.20 Mn |
| Jan 31, 2024 | 5.06 Mn |
| Oct 31, 2023 | 4.97 Mn |
| Jul 31, 2023 | 1.66 Mn |
| Apr 30, 2023 | 2.65 Mn |
| Jan 31, 2023 | 794,567.97 |
| Oct 31, 2022 | 1.99 Mn |
| Oct 31, 2021 | 284,094.58 |